Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pfizer Eyes Consumer Unit Spin-Off Or Sale Price North of $10 Bil.

This article was originally published in The Tan Sheet

Executive Summary

Pfizer has "no interest" in separately divesting individual products from its consumer division, CEO Hank McKinnell said during a Feb. 10 analysts presentation

Related Content

J&J Washes Hands Of Purell As GOJO Eyes Consumer Segment Growth
J&J Picks Up Listerine, Nicorette With $16.6 Bil. Purchase Of Pfizer OTCs
Pfizer Weighs Options For OTC Division As Investors Line Up For Purchase
Pfizer Consumer Healthcare Revenue Is “On Plan,” McKinnell Says
Bayer Poised To “Seize Opportunities” After Rapid Integration Of Roche OTCs
Colgate President Cook Slated For CEO Post After Mark’s 2007 Retirement
Chattem Looks To Tech: ‘Cool’ New Products Not What They Used To Be
Pfizer Consumer Business Not Critical During “Transition” Year
Pfizer Consumer Business Not Critical During “Transition” Year
Cool Mint Listerine PocketPaks Breath Strips Slated For Summer Launch





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts